NEW YORK (GenomeWeb News) — Sysmex Inostics said today that it has inked a collaboration agreement with Bayer Healthcare to develop blood-based companion diagnostics for targeted anti-cancer therapies being developed by Bayer.
NEW YORK (GenomeWeb News) – Bayer Healthcare and the Broad Institute today announced a strategic alliance to jointly discover and develop therapeutic agents that target cancer genome alterations.
NEW YORK (GenomeWeb News) – Bayer CropScience and KeyGene today announced a multiyear deal aimed at improving traits in several major agricultural crops.
Finnish bioinformatics firm MediSapiens has signed its first customer for OncoGenomics Explorer, a cloud computing-based application launched last September for use in cancer genomics research (
NEW YORK (GenomeWeb News) – Qiagen today said that it will collaborate with Bayer HealthCare on developing companion diagnostics for Bayer drugs with an initial focus on those that target solid tumors.
Teams led by researchers at George Mason University have published a pair of studies exploring protein signaling in breast and colon cancer that could offer new insights into treatments for the diseases.
By Adam Bonislawski
University of North Carolina researchers have developed a chemical proteomics approach to measure global kinase activity and used it to investigate drug resistance in triple-negative breast cancer.
NEW YORK (GenomeWeb News) – Rosetta Green and Bayer CropScience have signed an agreement directed at discovering and characterizing microRNA genes with the potential to improve cotton yields.
In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.
